# Phase 9 — Action 9.14 Residual Risk and Final Completion Gate

## Objective

Close the Phase 9 identity, authorization and tenant-isolation assessment
without confusing successful laboratory remediation with production
certification or zero residual risk.

## Completed Phase 9 assurance

Phase 9 established and tested controls covering:

- identity/account-type behavior;
- authentication and session/token lifecycle;
- authorization and resource ownership;
- cross-user and cross-role access boundaries;
- tenant/data authorization reasoning;
- delegated actions and tool authority;
- workload/service-account identity;
- secret and credential handling;
- negative authorization testing;
- bounded runtime verification;
- finding root cause and remediation;
- post-remediation regression;
- supporting-control responsibility transfer.

Action 9.11 records final finding dispositions for H9-12 through H9-19.

Actions 9.12 and 9.13 completed post-remediation regression and
control-responsibility assessment.

## Residual-risk register

### R9-01 — Encryption-key deployment assurance

The assessed lab does not establish a production-managed
`ENCRYPTION_KEY_SECRET`.

Impact:

Application-level confidentiality for protected database secrets depends on
deploying, protecting, rotating and recovering the encryption key correctly.

Required production control:

- configure a strong deployment-specific key;
- protect it using the approved secret-management system;
- limit administrative access;
- define rotation and recovery procedures;
- verify migration before retiring old key material.

Disposition:

**OPEN DEPLOYMENT ASSURANCE ITEM — not an unresolved H9-18/H9-19 code defect.**

---

### R9-02 — Legacy secret/token migration

The hardened code can read legacy records for migration compatibility.

Impact:

A deployment upgraded from an older version may still contain legacy raw or
historical ciphertext until rotation is executed.

Required production control:

- inventory affected encrypted columns;
- back up according to approved procedures;
- execute bounded key-aware migration;
- verify all expected rows use the current authenticated format;
- preserve rollback evidence.

Disposition:

**OPEN DEPLOYMENT MIGRATION ITEM.**

---

### R9-03 — OAuth provider-side revocation

Local token refresh, expiry and protected storage were assessed.

Explicit provider-side revocation behavior was not established by the current
Phase 9 trace.

Impact:

Local deletion or invalidation does not by itself prove immediate invalidation
at the external OAuth provider.

Required future assurance:

- identify provider revocation endpoint/contract;
- verify logout/account unlink/revocation behavior;
- verify failure and retry handling;
- verify token invalidity at the provider.

Disposition:

**OPEN PROVIDER-LIFECYCLE ASSURANCE ITEM.**

---

### R9-04 — External IdP / policy-engine deployment

Action 9.13 evaluated responsibility transfer conceptually.

Phase 9 does not claim a production Keycloak, OpenFGA or equivalent external
authorization deployment.

Required future assurance includes:

- issuer/audience/signature verification;
- user/subject binding;
- role/group mapping;
- tenant derivation;
- stale relationship behavior;
- fail-closed behavior;
- revocation propagation;
- application/policy parity.

Disposition:

**OPEN DEPLOYMENT-INTEGRATION ASSURANCE ITEM.**

---

### R9-05 — Full repository test-runner availability

The pinned runtime used for the closing H9-18/H9-19 work did not contain the
complete repository pytest environment.

Phase 9 compensated using:

- existing historical runtime evidence;
- direct security-property regression;
- Python syntax/import-level checks;
- real bounded PostgreSQL/Alembic migration proofs;
- explicit rollback and cleanup.

Required CI/release assurance:

Run the repository's supported test suite in the normal dependency-complete CI
environment before production release.

Disposition:

**OPEN CI/RELEASE ASSURANCE ITEM.**

---

### R9-06 — Laboratory infrastructure hardening

The local runtime repeatedly reports well-known MinIO development credentials.

This did not invalidate the bounded Phase 9 identity/authorization tests, but
those credentials are inappropriate for production.

Required production control:

Replace all default object-storage credentials with strong unique deployment
credentials and restrict network reachability.

Disposition:

**OPEN CROSS-PHASE DEPLOYMENT-HARDENING ITEM.**

## Risk acceptance boundary

Phase 9 completion means:

- the planned Phase 9 engineering actions are complete;
- identified code-level findings have recorded dispositions;
- implemented remediations have evidence;
- no known Phase 9 code defect remains intentionally hidden by the closeout;
- residual deployment/integration risks are explicitly carried forward.

Phase 9 completion does **not** mean:

- production certification;
- zero vulnerabilities;
- production Keycloak/OpenFGA validation;
- production key-management validation;
- OAuth-provider revocation validation;
- full-scale production telemetry or incident validation.

## Final evidence gate

Required completion records:

- Action 9.11: **COMPLETE**
- Action 9.12: **COMPLETE**
- Action 9.13: **COMPLETE**
- Action 9.14: **COMPLETE**

Finding disposition coverage:

- H9-12: recorded
- H9-13: recorded
- H9-14: recorded
- H9-15: recorded
- H9-16: recorded
- H9-17: recorded
- H9-18: recorded
- H9-19: recorded

## Final Phase 9 decision

All planned Phase 9 actions have reached an evidence-backed completion state
inside the authorized laboratory boundary.

Residual risks are explicitly registered and transferred to deployment,
integration, CI/release or later security phases as appropriate.

**ACTION 9.14: COMPLETE**

**PHASE 9: COMPLETE — 14/14 ACTIONS**
